Overview

Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether botulinum toxin A is effective in the treatment of neuropathic pain in spinal cord injury patients.
Phase:
Phase 4
Details
Lead Sponsor:
Catholic University of Korea Saint Paul's Hospital
Collaborators:
Medy-Tox
National Health Insurance Service Ilsan Hospital
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA